Metalidis C et al. |
Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity. |
2011 |
Transplantation |
pmid:21544031
|
Shihab FS et al. |
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study. |
2008 |
Transplantation |
pmid:18475181
|
Ekberg H |
Calcineurin inhibitor sparing in renal transplantation. |
2008 |
Transplantation |
pmid:18813097
|
Fischer L et al. |
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. |
2015 |
Transplantation |
pmid:26151607
|
Keenan RJ et al. |
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. |
1991 |
Transplantation |
pmid:1719668
|
Nakamura Y et al. |
Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator. |
2003 |
Transplantation |
pmid:12717187
|
Calmus Y et al. |
Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients. |
2010 |
Transplantation |
pmid:20495510
|
Ouyang J et al. |
Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections. |
2005 |
Transplantation |
pmid:15912108
|
Egli A et al. |
Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. |
2009 |
Transplantation |
pmid:19935369
|
Boyer O et al. |
Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil. |
2005 |
Transplantation |
pmid:15912111
|
Villanueva G and Baldwin D |
Rosiglitazone therapy of posttransplant diabetes mellitus. |
2005 |
Transplantation |
pmid:16340782
|
Numakura K et al. |
Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. |
2005 |
Transplantation |
pmid:16340785
|
Koneru B et al. |
Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era? |
1997 |
Transplantation |
pmid:9197350
|
Sugitani A et al. |
En bloc pancreas and kidney transplantation in a patient with limited vascular access. |
1997 |
Transplantation |
pmid:9197366
|
Shihab FS et al. |
Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. |
2009 |
Transplantation |
pmid:19202436
|
Furukawa H et al. |
The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. |
1992 |
Transplantation |
pmid:1373531
|
de Sandes-Freitas TV et al. |
Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. |
2015 |
Transplantation |
pmid:25929604
|
Sankary HN et al. |
FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. |
1998 |
Transplantation |
pmid:9798690
|
Pirsch JD et al. |
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9112351
|
Tanabe M et al. |
Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation. |
1994 |
Transplantation |
pmid:7518619
|
Bellon H et al. |
The Effect of Immunosuppression on Airway Integrity. |
2017 |
Transplantation |
pmid:28471870
|
Barten MJ et al. |
Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood. |
2004 |
Transplantation |
pmid:15114077
|
Kiuchi T |
CNIs: immediate benefits but storing problems for the future? |
2008 |
Transplantation |
pmid:18946338
|
Couzi L et al. |
Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients. |
2008 |
Transplantation |
pmid:18946343
|
Horner BM et al. |
Recipient damage after musculocutaneous transplant rejection. |
2008 |
Transplantation |
pmid:18946349
|
Kaufman DB et al. |
The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. |
1995 |
Transplantation |
pmid:7541579
|
Herzog D et al. |
Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. |
2006 |
Transplantation |
pmid:16534467
|
McDiarmid SV et al. |
Factors affecting growth after pediatric liver transplantation. |
1999 |
Transplantation |
pmid:10030286
|
Eckhoff DE et al. |
The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. |
2000 |
Transplantation |
pmid:10830224
|
Nakata Y et al. |
Tacrolimus and myocardial hypertrophy. |
2000 |
Transplantation |
pmid:10830241
|
Hanto DW and Chudzinski R |
What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus? |
2009 |
Transplantation |
pmid:19155968
|
Ericzon BG et al. |
Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9000664
|
Schena FP et al. |
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. |
2009 |
Transplantation |
pmid:19155978
|
Tamura K et al. |
Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. |
1995 |
Transplantation |
pmid:7539960
|
Fisher A et al. |
FK506 hepatotoxicity in liver allograft recipients. |
1995 |
Transplantation |
pmid:7539961
|
Valdivia LA et al. |
Dendritic cell replacement in long-surviving liver and cardiac xenografts. |
1993 |
Transplantation |
pmid:7689265
|
Pape E et al. |
Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations. |
2015 |
Transplantation |
pmid:26308424
|
Gruessner RW et al. |
Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study. |
1998 |
Transplantation |
pmid:9701258
|
Pascual J et al. |
Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. |
2010 |
Transplantation |
pmid:20335831
|
Sahara H et al. |
Beneficial effects of perioperative low-dose inhaled carbon monoxide on pulmonary allograft survival in MHC-inbred CLAWN miniature swine. |
2010 |
Transplantation |
pmid:21076382
|
Min SI et al. |
CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients. |
2010 |
Transplantation |
pmid:21076384
|
Chan L et al. |
Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness. |
2008 |
Transplantation |
pmid:18360262
|
Saad ER et al. |
Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. |
2008 |
Transplantation |
pmid:18360267
|
Pirenne J et al. |
Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model. |
1996 |
Transplantation |
pmid:8685944
|
Tsugita M et al. |
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. |
1996 |
Transplantation |
pmid:8685952
|
Stephen M et al. |
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine. |
1989 |
Transplantation |
pmid:2463701
|
Peduto G et al. |
Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression. |
2000 |
Transplantation |
pmid:10919579
|
Burger CI et al. |
Case report: drug interaction between tacrolimus and amiodarone with QT prolongation. |
2010 |
Transplantation |
pmid:20440199
|
Wong W et al. |
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? |
2005 |
Transplantation |
pmid:16082321
|
Krämer BK et al. |
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial. |
2012 |
Transplantation |
pmid:22858806
|